XML 49 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Operations - USD ($)
$ / shares in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Expenses:    
Research and development $ 4,763
Selling, general and administrative 196,621 178,516
Total expenses (196,621) (183,279)
Loss from operations (196,621) (183,279)
Other income    
Interest income 449
Gain on settlements of accounts payable 3,307
Total other income 3,756
Net loss $ (192,865) $ (183,279)
Net loss per share - basic and diluted (in dollars per share)
Weighted-average number of common shares outstanding - basic and diluted (in shares) 57,032,157 45,572,568